• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Who Gets CUT next? Name the departments already gone.













Endpoints reported last night that we are using Goldman Sachs to shop around our Hospital BU in order to sell it to either another company or a private equity firm.
So there’s that.